PharmaSynergy-Rx

The Event

PharmaSynergyRx is known for creating a focused and tailored event that caters to companies pursuing co-development, partnerships, licensing, and commercial deals.
The event always goes beyond the ordinary, offering a comprehensive programme that includes Business Development-tuned content, opportunities for informal networking, and structured B2B meetings.
Now in its 8th year, PharmaSynergyRx has solidified its position as a premier Rx-focused partnering event for both global and regional companies.

What to Expect

Clear Product Portfolio Focus

  • Primary, Niche, Branded, and Hybrid Generics
  • Value-Added Medicines (VAMs)
  • Specialty, Biosimilars
  • Legacy Products and NCEs
  • Technology Platforms: Dosage, Formulation, Delivery

1-2-1 Meetings & Networking

Your pre-scheduled time slots and content sessions are seamlessly woven into the fabric of the day, ensuring that your agenda is personalised, leaving no room for missed opportunities.

Valuable Information

We aim to provide diverse perspectives and strategic insights. In 2026, the event will feature compelling speakers discussing international growth, strategies, BD&L and portfolio approaches.

Partnering Platform

Venue

etcvenues: County Hall, Belvedere Rd, London SE1 7GP

PharmaSynergy-Rx Audience

We were delighted to welcome over 250 Business Development & Licensing executives from 60+ countries at the 2025 PharmaSynergy-Rx event.
Our analysis of business partnering models revealed a well-balanced audience: Out-licensing led with 40%, closely followed by In-licensing at 35%. Regional partnerships and distribution accounted for 30%, commercialisation 25%, product acquisitions 20%, co-development 18%, technology transfer 12%, and global rights 5%, and financing 3%.

We believe that everyone has the potential to achieve greatness and fulfill their dreams. That is why we are committed to providing innovative solutions and exceptional services that empower individuals to overcome obstacles and turn their aspirations into reality. With a strong focus on customer satisfaction and a team of experienced professionals, we strive to deliver unparalleled results and make a positive impact in the lives of our clients. Join us on this journey of empowerment, and let us help you make your dreams come true.

Companies Partnering at 2026 Event Include

Partners of Choice and Sponsors

Biolab Farmacêutica is a leading Brazilian pharmaceutical company, founded in 1997, operating in human prescription drugs, generics, OTC products, and animal health. It has multiple manufacturing and R&D facilities in Brazil, with a new large plant under construction to expand capacity. (See more)

Biolab offers a broad portfolio across numerous therapeutic areas, invests heavily in R&D and innovation, and emphasizes sustainability. The company exports internationally and ranks among the top pharmaceutical companies in Brazil.

ANFARM is an international pharmaceutical company providing licensing, exports, and third-party services across Europe, Canada, Asia, and emerging markets in MENA, LATAM, and Oceania. (See more)

ANFARM’s state of the art manufacturing facilities coupled with an exceptional team of R&D scientists provide the assurance of a smooth transition from lab to commercial scale, as well as in-depth scientific know-how for tech transfers, product development and development and/or optimization of lyophilization cycles Our main activities include: Licensing out & International Sales; Regulatory Affairs Services; New Product Development;Contract Development; Tech Transfer & Contract Manufacturing.

Media Partner in Japan

Join PharmaSynergy-Rx

Join us in London for 2 days of productive meetings and meaningful discussions.